Replay available

Lucid Diagnostics Inc. (LUCD) Q1 2026 Earnings Call

Lucid Diagnostics Inc. (NASDAQ: LUCD) Q1 2026 earnings conference call, held 2026-05-14. Replay captured from the company's public earnings webcast.

Thu, May 14, 2026 at 8:30 AMendedReplay
Lucid Diagnostics Inc. (LUCD) Q1 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Matt Riley

Vice President of Investor Relations, Lucid Diagnostics

Dr. Leishan Aklag

Chairman and Chief Executive Officer, Lucid Diagnostics

Dennis McGrath

Chief Financial Officer, Lucid Diagnostics

Ed Wu

Analyst, Ascendant Capital

Replay transcript excerpt

Good morning, and welcome to the Lucid Diagnostics First Quarter 2026 Business Update Conference Call. Please note that this event is being recorded. I would now like to turn the conference over to Matt Riley, Lucid Diagnostics Vice President of Investor Relations. Please go ahead. Thank you, Operator, and good morning, everyone. Thank you for participating in today's Business Update Call. Joining me today on the call are Dr. Leshawn Acklog, Chairman and Chief Executive Officer of Lucid Diagnostics, along with Dennis McGrath, Chief Financial Officer of Lucid Diagnostics. The press release announcing our business update and financial results is available on Lucid's website. Please take a moment to read the disclaimers and forward-looking statements in the press release. The business update, press release, and the conference call all include forward-looking statements, and these forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially from statements made. Factors that could cause actual results to differ are described in the disclaimer and in our filings with the SEC. For a list and a description of these and other important risks and uncertainties that may affect future operations, see Part 1, Item 1A, entitled Risk Factors and Lucid from this recent annual report on Forms 10-K filed with the SEC. and any subsequent updates filed in the court reports on Forms 10-Q and subsequent Forms 8-K. Except as required by law, LUCID disclaims any intentions or obligations to publicly update or revise any forward-looking statements to reflect changes in expectations on events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results wo...

More from Lucid Diagnostics Inc.